Atia Vision Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$42M
- Investors
-
10
Atia Vision General Information
Description
Developer of presbyopia-correcting medical devices designed to provide accommodating intraocular lenses. The company's devices naturally mimic the physiological lens's autofocusing capability without creating visual artifacts and its accommodating intraocular lens eliminates the need for glasses, thus restoring vision, enabling cataract and vision-impaired patients with an effective range of vision treatment.
Contact Information
Website
www.atiavision.comCorporate Office
- 550 Division Street
- Campbell, CA 95008
- United States
Corporate Office
- 550 Division Street
- Campbell, CA 95008
- United States
Atia Vision Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series E) | 02-Aug-2022 | $42M | Completed | Clinical Trials - General | ||
| 5. Later Stage VC (Series D) | 26-Apr-2019 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series C) | 09-Nov-2018 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series C) | 08-May-2017 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series B) | 01-Apr-2015 | $5M | $6.11M | Completed | Clinical Trials - General | |
| 1. Early Stage VC (Series A) | 05-Sep-2013 | $1.11M | $1.11M | Completed | Clinical Trials - General |
Atia Vision Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A1 | 1,692,328 | $0.000100 | $0.03 | $0.42 | $0.42 | 1x | $0.42 | 3.68% |
| Series A | 2,750,000 | $0.000100 | $0.01 | $0.18 | $0.18 | 1x | $0.18 | 5.98% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Atia Vision Patents
Atia Vision Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250235308-A1 | Accommodating intraocular lens | Pending | 26-Aug-2014 | ||
| FR-1368119-A | Process for protecting plants against the effects of frost | Inactive | 21-Jan-1963 |
Atia Vision Signals
Atia Vision Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| PA MedTech VC Fund | Corporate Venture Capital | Minority | ||
| AMED Ventures | Venture Capital | Minority | ||
| ShangBay Capital | Venture Capital | Minority | ||
| Cormorant Asset Management | PE/Buyout | Minority | ||
| Grant Park Ventures | Venture Capital | Minority |
Atia Vision FAQs
-
When was Atia Vision founded?
Atia Vision was founded in 2012.
-
Where is Atia Vision headquartered?
Atia Vision is headquartered in Campbell, CA.
-
What is the size of Atia Vision?
Atia Vision has 15 total employees.
-
What industry is Atia Vision in?
Atia Vision’s primary industry is Therapeutic Devices.
-
Is Atia Vision a private or public company?
Atia Vision is a Private company.
-
What is the current valuation of Atia Vision?
The current valuation of Atia Vision is .
-
What is Atia Vision’s current revenue?
The current revenue for Atia Vision is .
-
How much funding has Atia Vision raised over time?
Atia Vision has raised $78.1M.
-
Who are Atia Vision’s investors?
PA MedTech VC Fund, AMED Ventures, ShangBay Capital, Cormorant Asset Management, and Grant Park Ventures are 5 of 10 investors who have invested in Atia Vision.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process